Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Freise

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Veterinary Pharmacology and Therapeutics|July 5, 2022
Multicentered masked placebo-controlled phase 3 clinical study of an extended duration transdermal buprenorphine solution for post-operative pain in catsTerrence P Clark, Deborah D Linton, Kevin J Freise, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 17, 2008
Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheepKevin J Freise, John A Widness, Robert L Schmidt, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 5, 2022
Multicentered masked placebo-controlled phase 2 clinical study of an extended duration transdermal buprenorphine solution for postoperative pain in catsTerrence P Clark, Deborah D Linton, Kevin J Freise, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 22, 2008
Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular responseKevin J Freise, Robert L Schmidt, John A Widness, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 5, 2022
Single-dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in catsKevin J Freise, Craig Reinemeyer, Katherine Warren, et al.
Journal of Cancer|August 5, 2017
Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia TrialsSuresh K Agarwal, Naveen Mangal, Rajeev M Menon, et al.
Journal of Clinical Pharmacology|August 22, 2018
Are Clinical Therapeutic Protein-Drug Interaction Studies Needed When Disease Modification Is Driving the Potential Interaction?Yinuo Pang, Matthew R Rosebraugh, Kevin J Freise, et al.
Pharmaceutical Research|April 26, 2007
Increased erythropoietin elimination in fetal sheep following chronic phlebotomyKevin J Freise, John A Widness, Jeffrey L Segar, et al.
Clinical Drug Investigation|December 3, 2016
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy VolunteersAhmed Hamed Salem, Beibei Hu, Kevin J Freise, et al.
Leukemia & Lymphoma|August 12, 2017
Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphomaApurvasena Parikh, Sathej Gopalakrishnan, Kevin J Freise, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Veterinary Pharmacology and Therapeutics|July 5, 2022
Multicentered masked placebo-controlled phase 3 clinical study of an extended duration transdermal buprenorphine solution for post-operative pain in catsTerrence P Clark, Deborah D Linton, Kevin J Freise, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 17, 2008
Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheepKevin J Freise, John A Widness, Robert L Schmidt, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 5, 2022
Multicentered masked placebo-controlled phase 2 clinical study of an extended duration transdermal buprenorphine solution for postoperative pain in catsTerrence P Clark, Deborah D Linton, Kevin J Freise, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 22, 2008
Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular responseKevin J Freise, Robert L Schmidt, John A Widness, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 5, 2022
Single-dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in catsKevin J Freise, Craig Reinemeyer, Katherine Warren, et al.
Journal of Cancer|August 5, 2017
Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia TrialsSuresh K Agarwal, Naveen Mangal, Rajeev M Menon, et al.
Journal of Clinical Pharmacology|August 22, 2018
Are Clinical Therapeutic Protein-Drug Interaction Studies Needed When Disease Modification Is Driving the Potential Interaction?Yinuo Pang, Matthew R Rosebraugh, Kevin J Freise, et al.
Pharmaceutical Research|April 26, 2007
Increased erythropoietin elimination in fetal sheep following chronic phlebotomyKevin J Freise, John A Widness, Jeffrey L Segar, et al.
Clinical Drug Investigation|December 3, 2016
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy VolunteersAhmed Hamed Salem, Beibei Hu, Kevin J Freise, et al.
Leukemia & Lymphoma|August 12, 2017
Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphomaApurvasena Parikh, Sathej Gopalakrishnan, Kevin J Freise, et al.
Pageof 4